PharmaResources (Shanghai) (China) Probability of Future Stock Price Finishing Over 24.0
| 301230 Stock | 31.33 0.26 0.82% |
PharmaResources |
PharmaResources (Shanghai) Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PharmaResources (Shanghai) for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PharmaResources (Shanghai) can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PharmaResources (Shanghai) had very high historical volatility over the last 90 days | |
| PharmaResources (Shanghai) has high likelihood to experience some financial distress in the next 2 years | |
| About 53.0% of the company shares are owned by insiders or employees |
PharmaResources (Shanghai) Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PharmaResources Stock often depends not only on the future outlook of the current and potential PharmaResources (Shanghai)'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PharmaResources (Shanghai)'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 139.9 M |
PharmaResources (Shanghai) Technical Analysis
PharmaResources (Shanghai)'s future price can be derived by breaking down and analyzing its technical indicators over time. PharmaResources Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PharmaResources Co Ltd. In general, you should focus on analyzing PharmaResources Stock price patterns and their correlations with different microeconomic environments and drivers.
PharmaResources (Shanghai) Predictive Forecast Models
PharmaResources (Shanghai)'s time-series forecasting models is one of many PharmaResources (Shanghai)'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PharmaResources (Shanghai)'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about PharmaResources (Shanghai)
Checking the ongoing alerts about PharmaResources (Shanghai) for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PharmaResources (Shanghai) help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PharmaResources (Shanghai) had very high historical volatility over the last 90 days | |
| PharmaResources (Shanghai) has high likelihood to experience some financial distress in the next 2 years | |
| About 53.0% of the company shares are owned by insiders or employees |
Other Information on Investing in PharmaResources Stock
PharmaResources (Shanghai) financial ratios help investors to determine whether PharmaResources Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmaResources with respect to the benefits of owning PharmaResources (Shanghai) security.